Viewing Study NCT01751568


Ignite Creation Date: 2025-12-24 @ 5:38 PM
Ignite Modification Date: 2026-02-20 @ 10:12 PM
Study NCT ID: NCT01751568
Status: COMPLETED
Last Update Posted: 2021-11-05
First Post: 2012-12-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-11-12
Start Date Type: ACTUAL
Primary Completion Date: 2019-11-27
Primary Completion Date Type: ACTUAL
Completion Date: 2019-11-27
Completion Date Type: ACTUAL
First Submit Date: 2012-12-14
First Submit QC Date: None
Study First Post Date: 2012-12-18
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2020-11-24
Results First Submit QC Date: None
Results First Post Date: 2020-12-21
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-11-03
Last Update Post Date: 2021-11-05
Last Update Post Date Type: ACTUAL